Abstract
Purpose
To measure the impact on pain relief and patient quality of life using embolization radio-frequency ablation and cementoplasty (ERC) for local combination therapeutic management of painful pelvic bone metastasis of renal cell carcinoma (RCC).
Materials and Methods
This prospective monocentric registry was approved by our Local Institutional Review Board. Between January 2008 and January 2013, all consecutive patients who fully met the inclusion criteria were enrolled in the ERC-procedure prospective registry. They were assigned to follow-up at discharge and again at 1 and 6 months. Efficacy was evaluated using a pain visual analog scale (VAS), and narcotic consumption and quality of life were assessed using the Brief Pain Inventory questionnaire.
Results
Fifty-two patients were enrolled, among whom 58 lesions were treated. Technical success was obtained in all procedures. The median VAS score decreased from 7 ± 1.4 (ranges 5–10) at baseline to 3 ± 1.5 (ranges 0–6) at discharge, 2 ± 1.5 (ranges 0–5) at 1 month (p < 0.0001), and 2 ± 1.6 (ranges 0–5) at 6 months. In 28 patients (54 %), narcotic consumption was halved at discharge and halved in 40 (77 %) patients at 1 and 6 months compared with baseline. Five patients had complete pain relief at 1 month. A major improvement in quality of life, especially regarding mood and motion, was observed in all patients.
Conclusion
This specific approach to painful bone metastasis is efficient and safe and yields sustained results. The ERC procedure could be suggested for patients with RCC bone metastasis.
Similar content being viewed by others
Abbreviations
- RCC:
-
Renal cell cancer
- ECOGps:
-
Eastern Cooperative Oncology Group Performance Status
- ASA:
-
American Society of Anesthesiologists
- ERC:
-
Embolization radio-frequency ablation and cementoplasty
- RFA:
-
Radio-Frequency Ablation
- BPI:
-
Brief pain inventory
- VAS:
-
Visual analog scale
- PMMA:
-
Polymethyl methacrylate
- PCA:
-
Patient control analgesia
- MED:
-
Morphine-equivalent daily dose
References
Badalian G, Derecskei K, Szendroi A, Szendroi M, Timar J (2007) EGFR and VEGFR2 protein expressions in bone metastases of clear cell renal cancer. Anticancer Res 27(2):889–894
Beuselinck B, Oudard S, Rixe O et al (2011) Negative impact of bone metastasis on outcome in clear-cell renal cell carcinoma treated with sunitinib. Ann Oncol 22(4):794–800
Boureau F, Luu M, Doubrere JF, Gay C (1984) Construction of a questionnaire for the self-evaluation of pain using a list of qualifiers. Comparison with Melzack’s McGill Pain Questionnaire. Therapie 39(2):119–129
Callstrom MR, Atwell TD, Charboneau JW et al (2006) Painful metastases involving bone: percutaneous image-guided cryoablation—Prospective trial interim analysis. Radiology 241(2):572–580
Callstrom MR, Dupuy DE, Solomon SB et al (2013) Percutaneous image-guided cryoablation of painful metastases involving bone: multicenter trial. Cancer 119(5):1033–1041
Callstrom MR, York JD, Gaba RC et al (2009) Research reporting standards for image-guided ablation of bone and soft tissue tumors. J Vasc Interv Radiol 20(12):1527–1540
Carrafiello G, Dionigi G, Boni L et al (2011) Current role of interventions in metastatic kidney tumors: single center experience. Updates Surg 63(4):259–269
Carrafiello G, Lagana D, Pellegrino C et al (2009) Percutaneous imaging-guided ablation therapies in the treatment of symptomatic bone metastases: preliminary experience. Radiol Med 114(4):608–625
Chatziioannou AN, Johnson ME, Pneumaticos SG, Lawrence DD, Carrasco CH (2000) Preoperative embolization of bone metastases from renal cell carcinoma. Eur Radiol 10(4):593–596
Chiras J, Adem C, Vallee JN, Spelle L, Cormier E, Rose M (2004) Selective intra-arterial chemoembolization of pelvic and spine bone metastases. Eur Radiol 14(10):1774–1780
Courtheoux P, Alachkar F, Casasco A et al (1985) Chemoembolization of lumbar spine metastases A preliminary study. J Neuroradiol 12(2):151–162
Emmanouilides C, Chourmouzi D, Dedes I, Pantoleon D, Mantziari P, Drevelengas A (2009) Successful management of bulky osseous metastasis of renal cell carcinoma with selective arterial embolization and radiofrequency ablation: a case report. Cases J 2:6484
Forauer AR, Kent E, Cwikiel W, Esper P, Redman B (2007) Selective palliative transcatheter embolization of bony metastases from renal cell carcinoma. Acta Oncol 46(7):1012–1018
Guzman R, Dubach-Schwizer S, Heini P et al (2005) Preoperative transarterial embolization of vertebral metastases. Eur Spine J 14(3):263–268
Haynes SR, Lawler PG (1995) An assessment of the consistency of ASA physical status classification allocation. Anaesthesia 50(3):195–199
Heran MK, Legiehn GM, Munk PL (2006) Current concepts and techniques in percutaneous vertebroplasty. Orthop Clin North Am 37(3):409–434 vii
Ishiyama H, Shibata A, Niino K, Hosoya T (2004) Relationship between morphine and radiotherapy for management of symptomatic bone metastases from lung cancer. Support Care Cancer 12(10):743–745
Kato T, Nemoto R, Mori H, Takahashi M, Harada M (1981) Arterial chemoembolization with mitomycin C microcapsules in the treatment of primary or secondary carcinoma of the kidney, liver, bone and intrapelvic organs. Cancer 48(3):674–680
Kickuth R, Waldherr C, Hoppe H et al (2008) Interventional management of hypervascular osseous metastasis: role of embolotherapy before orthopedic tumor resection and bone stabilization. AJR Am J Roentgenol 191(6):W240–W247
Lane MD, Le HB, Lee S et al (2011) Combination radiofrequency ablation and cementoplasty for palliative treatment of painful neoplastic bone metastasis: experience with 53 treated lesions in 36 patients. Skeletal Radiol 40(1):25–32
Mikami S, Katsube K, Oya M et al (2009) Increased RANKL expression is related to tumour migration and metastasis of renal cell carcinomas. J Pathol 218(4):530–539
Motzer RJ, Hutson TE, Tomczak P et al (2009) Overall survival and updated results for sunitinib compared with interferon alfa in patients with metastatic renal cell carcinoma. J Clin Oncol 27(22):3584–3590
Nakatsuka A, Yamakado K, Maeda M et al (2004) Radiofrequency ablation combined with bone cement injection for the treatment of bone malignancies. J Vasc Interv Radiol 15(7):707–712
Oken MM, Creech RH, Tormey DC et al (1982) Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5(6):649–655
Pereira J, Lawlor P, Vigano A, Dorgan M, Bruera E (2001) Equianalgesic dose ratios for opioids. A critical review and proposals for long-term dosing. J Pain Symptom Manag 22(2):672–687
Pusceddu C, Sotgia B, Fele RM, Melis L (2013) Treatment of bone metastases with microwave thermal ablation. J Vasc Interv Radiol 24(2):229–233
Staahl C, Christrup LL, Andersen SD, Arendt-Nielsen L, Drewes AM (2006) A comparative study of oxycodone and morphine in a multimodal, tissue-differentiated experimental pain model. Pain 123(1–2):28–36
Staehler M, Haseke N, Stadler T et al (2010) Feasibility and effects of high-dose hypofractionated radiation therapy and simultaneous multikinase inhibition with sunitinib in progressive metastatic renal cell cancer. Urol Oncol 30(3):290–293
Sun S, Lang EV (1998) Bone metastases from renal cell carcinoma: preoperative embolization. J Vasc Interv Radiol 9(2):263–269
Thacker PG, Callstrom MR, Curry TB et al (2011) Palliation of painful metastatic disease involving bone with imaging-guided treatment: comparison of patients’ immediate response to radiofrequency ablation and cryoablation. AJR Am J Roentgenol 197(2):510–515
Urch C (2004) The pathophysiology of cancer-induced bone pain: current understanding. Palliat Med 18(4):267–274
Woodward E, Jagdev S, McParland L et al (2011) Skeletal complications and survival in renal cancer patients with bone metastases. Bone 48(1):160–166
Woolf CJ, Allchorne A, Safieh-Garabedian B, Poole S (1997) Cytokines, nerve growth factor and inflammatory hyperalgesia: the contribution of tumour necrosis factor alpha. Br J Pharmacol 121(3):417–424
Zekri J, Ahmed N, Coleman RE, Hancock BW (2001) The skeletal metastatic complications of renal cell carcinoma. Int J Oncol 19(2):379–382
Acknowledgments
The authors acknowledge MingDe Lin PhD, for helpful comments and language editing.
Conflict of interest
All the authors have no conflict of interest to declare.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Pellerin, O., Medioni, J., Vulser, C. et al. Management of Painful Pelvic Bone Metastasis of Renal Cell Carcinoma Using Embolization, Radio-frequency Ablation, and Cementoplasty: A Prospective Evaluation of Efficacy and Safety. Cardiovasc Intervent Radiol 37, 730–736 (2014). https://doi.org/10.1007/s00270-013-0740-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00270-013-0740-x